MENU
+Compare
FZMD
Stock ticker: OTC
AS OF
Jun 5 closing price
Price
$0.07
Change
+$0.01 (+16.67%)
Capitalization
5.99M

FZMD Fuse Medical, Inc. Forecast, Technical & Fundamental Analysis

Fuse Medical Inc is a y is a manufacturer, distributor, and wholesaler of medical device implants, offering a broad portfolio of orthopedic implants and biologics... Show more

FZMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for FZMD with price predictions
Jul 03, 2025

FZMD in downward trend: price may decline as a result of having broken its higher Bollinger Band on June 05, 2025

FZMD broke above its upper Bollinger Band on June 05, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 25 similar instances where the stock broke above the upper band. In of the 25 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 50-day moving average for FZMD moved below the 200-day moving average on June 26, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where FZMD's RSI Oscillator exited the oversold zone, of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

FZMD moved above its 50-day moving average on July 02, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for FZMD crossed bullishly above the 50-day moving average on July 02, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (24.348). P/E Ratio (1.735) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (0.349) is also within normal values, averaging (42.660).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. FZMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FZMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
FZMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
1565 N. Central Expressway
Phone
+1 469 862-3030
Employees
31
Web
https://www.fusemedical.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TUYA2.450.12
+5.15%
Tuya
PCYO11.090.10
+0.91%
Pure Cycle Corp
CPNG30.290.26
+0.87%
Coupang
KNF80.60-0.61
-0.75%
Knife River Corp
BANL0.78-0.13
-14.41%
CBL International Limited

FZMD and Stocks

Correlation & Price change

A.I.dvisor tells us that FZMD and GNGBY have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FZMD and GNGBY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FZMD
1D Price
Change %
FZMD100%
N/A
GNGBY - FZMD
16%
Poorly correlated
-0.98%
DSRLF - FZMD
9%
Poorly correlated
N/A
GNNDY - FZMD
7%
Poorly correlated
N/A
FSPKF - FZMD
6%
Poorly correlated
N/A
ESLOY - FZMD
6%
Poorly correlated
-1.16%
More